Baystate Wealth Management’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$9.1K Buy
831
+343
+70% +$3.37K ﹤0.01% 745
2023
Q3
$5.36K Sell
488
-229
-32% -$3.27K ﹤0.01% 677
2023
Q2
$11.3K Hold
717
﹤0.01% 548
2023
Q1
$9.35K Hold
717
﹤0.01% 580
2022
Q4
$8K Hold
717
﹤0.01% 612
2022
Q3
$11K Hold
717
﹤0.01% 519
2022
Q2
$6K Hold
717
﹤0.01% 640
2022
Q1
$9K Buy
717
+75
+12% +$1.05K ﹤0.01% 589
2021
Q4
$15K Buy
642
+345
+116% +$8.35K ﹤0.01% 506
2021
Q3
$5K Buy
+297
New +$4.47K ﹤0.01% 592

Other funds holding ENVX

Baystate Wealth Management's ENVX Position: Q4 2023 in Review

Baystate Wealth Management increased its Enovix (ENVX) stake by 70% in Q4 2023, buying an estimated $3.37K and bringing the position to 831 shares worth $9.1K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Baystate Wealth Management first reported a position in ENVX in Q3 2021 and has held it in 10 quarters since. The position peaked at $15K in Q4 2021. 286 funds tracked by Wall St. Rank hold ENVX as of Q4 2023.

  • Baystate Wealth Management held 831 shares of Enovix worth $9.1K as of Q4 2023.
  • Baystate Wealth Management bought 343 Enovix shares in Q4 2023, an estimated $3.37K.
  • Enovix made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #745 holding.
  • Baystate Wealth Management first reported a position in Enovix in Q3 2021 and has held it in 10 quarters since.
  • Baystate Wealth Management's Enovix position peaked at $15K in Q4 2021.
  • 286 funds tracked by Wall St. Rank held Enovix as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.